a developer of the INTERCEPT Blood System for platelets and plasma
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, CERS has been loosely correlated with MASS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then MASS could also see price increases.
Ticker / NAME | Correlation To CERS | 1D Price Change % | ||
---|---|---|---|---|
CERS | 100% | -3.10% | ||
MASS - CERS | 52% Loosely correlated | -5.82% | ||
FLGT - CERS | 49% Loosely correlated | -3.19% | ||
KIDS - CERS | 45% Loosely correlated | -4.54% | ||
VCYT - CERS | 44% Loosely correlated | -3.99% | ||
INMD - CERS | 43% Loosely correlated | -5.92% | ||
More |
Ticker / NAME | Correlation To CERS | 1D Price Change % |
---|---|---|
CERS | 100% | -3.10% |
medical research theme (128 stocks) | 49% Loosely correlated | +0.46% |
medical service theme (156 stocks) | 47% Loosely correlated | +0.31% |
Medical Specialties theme (446 stocks) | 45% Loosely correlated | +0.28% |
Medical Specialties theme (433 stocks) | 45% Loosely correlated | +0.31% |
plasma-based theme (2 stocks) | 41% Loosely correlated | -0.30% |
More |